Return on Equity (ROE)
Updated 222h ago
Sector Performance
47th percentileIEX
12.7%
Sector Median
13.8%
Sector Avg
31.4%
Deep Analysis
The current Return on Equity (ROE) of 12.7% means that for every dollar of shareholders' equity, the company generated 12.7 cents in net profit over the last twelve months, a common measure of profitability.
This is slightly below the sector median of 13.8%, placing IEX in the 46th percentile among its peers, meaning it performs worse than about 54% of similar companies. Trend data is not available: the year-over-year change, quarter-over-quarter change, and historical values beyond the single 12.7% figure are all listed as N/A, so no direction can be inferred. The combination of a ROE below the sector median with no trend information offers neither a clear opportunity nor a distinct risk, leaving the investment case ambiguous. This neutral profile directly supports the overall NEUTRAL verdict, as the metric fails to provide a compelling reason to upgrade or downgrade the stock.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about IEX?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
Who are IEX's closest peers by Return on Equity (ROE)?
The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master IEX's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full IEX research report →IEX
12.7%
Sector Median
13.8%
Sector Avg
31.4%
How IEX's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.